top
BRAINLIFE NEWSLETTER
Volume 2, Number 16 - 5 September 2003

Volume 2
Archive


Contents


Epidemiology & Risk Factors
Integrative Medicine
Prognosis & Outcome
Treatment

Epidemiology & Risk Factors


Burkhard C, Di Patre PL, Schuler D, Schuler G, Yasargil MG, Yonekawa Y, Lutolf UM, Kleihues P, Ohgaki H
A population-based study of the incidence and survival rates in patients with pilocytic astrocytoma
J Neurosurg. 2003 Jun;98(6):1170-4 


Integrative Medicine


Haase H, Watjen W, Beyersmann D
Zinc induces apoptosis that can be suppressed by lanthanum in C6 rat glioma cells
Biol Chem 2001 Aug;382(8):1227-34 

Prasad KN, Ramanujam S, Gaudreau D
Vitamin E induces morphological differentiation and increases the effect of ionizing radiation on neuroblastoma cells in culture
Proc Soc Exp Biol Med 1979 Sep;161(4):570-3

Sun L, Yoshii Y, Miyagi K, Ishida A
Proliferation inhibition of glioma cells by vitamin K2
No Shinkei Geka 1999 Feb;27(2):119-25


Prognosis & Outcome


Kuznetsov YE, Caramanos Z, Antel SB, Preul MC, Leblanc R, Villemure JG, Pokrupa R, Olivier A, Sadikot A, Arnold DL
Proton magnetic resonance spectroscopic imaging can predict length of survival in patients with supratentorial gliomas
Neurosurgery. 2003 Sep;53(3):565-76


Treatment


Bakish J, Hargrave D, Tariq N, Laperriere N, Rutka JT, Bouffet E
Evaluation of dietetic intervention in children with medulloblastoma or supratentorial primitive neuroectodermal tumors
Cancer. 2003 Sep 1;98(5):1014-20


Cappuzzo F, Calandri C, Bartolini S, Crino L
ZD 1839 in patients with brain metastases from non-small-cell lung cancer (NSCLC): report of four cases
Br J Cancer. 2003 Jul 21;89(2):246-7


Hanzely Z, Polgar C, Fodor J, Brucher JM, Vitanovics D, Mangel LC, Afra D
Role of early radiotherapy in the treatment of supratentorial WHO Grade II astrocytomas: long-term results of 97 patients
J Neurooncol. 2003 Jul;63(3):305-12 

Kanzawa T, Germano IM, Kondo Y, Ito H, Kyo S, Kondo S
Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide
Br J Cancer. 2003 Sep 1;89(5):922-929 

Loeffler JS, Niemierko A, Chapman PH
Second tumors after radiosurgery: tip of the iceberg or a bump in the road?
Neurosurgery. 2003 Jun;52(6):1436-40; discussion 1440-2 

Newlands ES, Foster T, Zaknoen S
Phase I study of temozolomide (TMZ) combined with procarbazine (PCB) in patients with gliomas
Br J Cancer. 2003 Jul 21;89(2):248-51

The Neuro-Oncology Working Group Of The German Cancer Society
Neuro-oncology working group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma
J Clin Oncol. 2003 Sep 1;21(17):3276-84 

Salvati M, Frati A, Russo N, Caroli E, Polli FM, Minniti G, Delfini R
Radiation-induced gliomas: report of 10 cases and review of the literature
Surg Neurol. 2003 Jul;60(1):60-7; discussion 67

bottom


HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
| BrainLife Newsletter |
Children's Corner | E-mail Alerts | Journals | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP bottom